PerkinElmer Agrees to Buy CambridgeSoft, Completes ArtusLabs Purchase | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today announced two acquisitions totaling $220 million in aggregate to expand its informatics and software offerings and enable customers to access and share enterprise-wide data "for faster, more informed scientific decisions."

The Waltham, Mass.-based firm has signed a definitive agreement to acquire CambridgeSoft in one deal and completed its purchase of ArtusLabs in the other. The CambridgeSoft acquisition is expected to close in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.